Home ETF List About

Portfolio Holdings Detail for ISIN IE0031442068
Stock Name / FundiShares Core S&P 500 UCITS ETF USD (Dist)
IssuerBlackrock
Entity holding fund iShares Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300YDM1GFZR5B4U80
ETF TickerIDUS(USD) LSE
ETF TickerIDUS.LS(USD) CXE
ETF TickerIUSA.AS(EUR) CXE
ETF TickerIUSA.DE(EUR) CXE
ETF TickerIUSA.LS(GBX) CXE
ETF TickerIUSA.MI(EUR) CXE
ETF TickerIUSAz(USD) CXE
ETF TickerIUSA(EUR) ETF Plus
ETF TickerIDUS.L(GBP) LSE

Holdings detail for SOLV

Stock NameSolventum Corp.
TickerSOLV(USD) NYSE
TYPECommon Stock
CountryUSA
ISINUS83444M1018

Show aggregate SOLV holdings

News associated with SOLV

Wells Fargo & Company Issues Positive Forecast for Solventum (NYSE:SOLV) Stock Price
Solventum (NYSE:SOLV – Get Free Report) had its price target upped by equities researchers at Wells Fargo & Company from $79.00 to $82.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage presently has an “equal weight” rating on the stock. Wells Fargo & Company‘s price target suggests a potential upside of […] - 2025-09-17 03:06:58
Solventum Completes Sale Of Purification & Filtration Business; Raises Annual Earnings Outlook
(RTTNews) - Solventum Corporation (SOLV) Tuesday said that it has completed the sale of its Purification & Filtration business to Thermo Fisher Scientific Inc. (TMO) for $4 billion in cash. - 2025-09-02 10:10:37
Solventum (NYSE:SOLV) Rating Increased to Strong-Buy at Wall Street Zen
Solventum (NYSE:SOLV – Get Free Report) was upgraded by stock analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a report issued on Monday. Several other equities research analysts have also issued reports on SOLV. KeyCorp started coverage on Solventum in a report on Friday, June 6th. They set a […] - 2025-09-01 03:10:44
Solventum (NYSE:SOLV) Stock Rating Lowered by Wall Street Zen
Solventum (NYSE:SOLV – Get Free Report) was downgraded by investment analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research note issued to investors on Sunday. A number of other brokerages have also recently commented on SOLV. Morgan Stanley upgraded shares of Solventum from an “equal weight” rating to […] - 2025-08-24 06:14:43
Solventum Corporation (NYSE:SOLV) Shares Sold by Maryland State Retirement & Pension System
Maryland State Retirement & Pension System lessened its stake in Solventum Corporation (NYSE:SOLV – Free Report) by 18.2% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 6,479 shares of the company’s stock after selling 1,439 shares during the quarter. Maryland State Retirement […] - 2025-08-15 04:51:01
Solventum Announces Pricing Of Secondary Offering Of 8.80 Mln Common Stock
(RTTNews) - Solventum Corp. (SOLV) announced the pricing of the secondary offering of 8.80 million shares of its common stock, which is expected to result in gross proceeds of about $648 million to 3M Company. All of the shares of common stock are being sold by the Selling Shareh - 2025-08-14 00:33:56
Solventum Corporation (NYSE:SOLV) Shares Purchased by Charles Schwab Investment Management Inc.
Charles Schwab Investment Management Inc. boosted its holdings in Solventum Corporation (NYSE:SOLV – Free Report) by 2.2% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,173,960 shares of the company’s stock after buying an additional 24,762 shares during the quarter. Charles Schwab Investment Management […] - 2025-08-13 05:10:47
Blair William & Co. IL Sells 552 Shares of Solventum Corporation (NYSE:SOLV)
Blair William & Co. IL lessened its stake in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 4.8% in the 1st quarter, Holdings Channel.com reports. The institutional investor owned 11,010 shares of the company’s stock after selling 552 shares during the period. Blair William & Co. IL’s holdings in Solventum were worth $837,000 at […] - 2025-08-11 06:24:58
Federated Hermes Inc. Trims Position in Solventum Corporation (NYSE:SOLV)
Federated Hermes Inc. trimmed its holdings in Solventum Corporation (NYSE:SOLV – Free Report) by 67.6% in the first quarter, Holdings Channel.com reports. The institutional investor owned 764 shares of the company’s stock after selling 1,595 shares during the quarter. Federated Hermes Inc.’s holdings in Solventum were worth $58,000 as of its most recent filing with […] - 2025-08-11 05:04:58
Solventum (NYSE:SOLV) Price Target Raised to $94.00
Solventum (NYSE:SOLV – Free Report) had its price objective upped by Piper Sandler from $87.00 to $94.00 in a research report sent to investors on Friday,Benzinga reports. The brokerage currently has an overweight rating on the stock. A number of other equities analysts also recently weighed in on the company. Morgan Stanley raised Solventum from […] - 2025-08-11 03:08:46
XTX Topco Ltd Grows Stock Position in Solventum Corporation (NYSE:SOLV)
XTX Topco Ltd lifted its position in Solventum Corporation (NYSE:SOLV – Free Report) by 26.8% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 6,417 shares of the company’s stock after purchasing an additional 1,356 shares during the quarter. XTX Topco Ltd’s […] - 2025-08-08 04:38:55
Noteworthy Thursday Option Activity: AKAM, EXPE, SOLV
Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in Akamai Technologies Inc (Symbol: AKAM), where a total of 8,566 contracts have traded so far, representing approximately 856,600 underlying shares. That amounts to about 5 - 2025-08-07 14:17:28
Financial Analysis: Solventum (NYSE:SOLV) and BG Medicine (OTCMKTS:BGMD)
BG Medicine (OTCMKTS:BGMD – Get Free Report) and Solventum (NYSE:SOLV – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, earnings, dividends and institutional ownership. Valuation & Earnings This table compares BG Medicine and […] - 2025-08-05 02:41:00
Solventum Corporation (NYSE:SOLV) Receives $84.38 Average Target Price from Brokerages
Shares of Solventum Corporation (NYSE:SOLV – Get Free Report) have earned an average rating of “Hold” from the eleven brokerages that are covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, six have given a hold recommendation and four have assigned a buy recommendation to the company. […] - 2025-08-01 02:50:51
Universal Beteiligungs und Servicegesellschaft mbH Buys 584 Shares of Solventum Corporation (NYSE:SOLV)
Universal Beteiligungs und Servicegesellschaft mbH increased its stake in Solventum Corporation (NYSE:SOLV – Free Report) by 1.1% during the 1st quarter, Holdings Channel reports. The firm owned 53,143 shares of the company’s stock after purchasing an additional 584 shares during the quarter. Universal Beteiligungs und Servicegesellschaft mbH’s holdings in Solventum were worth $4,041,000 at the […] - 2025-07-29 05:22:58
7,059 Shares in Solventum Corporation (NYSE:SOLV) Purchased by Y Intercept Hong Kong Ltd
Y Intercept Hong Kong Ltd acquired a new stake in Solventum Corporation (NYSE:SOLV – Free Report) during the first quarter, according to its most recent 13F filing with the SEC. The fund acquired 7,059 shares of the company’s stock, valued at approximately $537,000. Several other institutional investors have also added to or reduced their stakes […] - 2025-07-28 06:02:51
New York State Common Retirement Fund Reduces Holdings in Solventum Corporation (NYSE:SOLV)
New York State Common Retirement Fund lowered its position in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 24.1% during the first quarter, Holdings Channel reports. The fund owned 67,549 shares of the company’s stock after selling 21,500 shares during the quarter. New York State Common Retirement Fund’s holdings in Solventum were worth $5,136,000 […] - 2025-07-22 07:09:10
Solventum Corporation (NYSE:SOLV) Shares Sold by Cwm LLC
Cwm LLC cut its holdings in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 13.2% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 15,875 shares of the company’s stock after selling 2,420 shares during the period. Cwm LLC’s holdings in Solventum […] - 2025-07-21 05:18:49
Cerity Partners LLC Buys 1,294 Shares of Solventum Corporation (NYSE:SOLV)
Cerity Partners LLC grew its stake in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 2.8% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 47,466 shares of the company’s stock after buying an additional 1,294 shares during the quarter. Cerity Partners […] - 2025-07-18 04:55:04
Solventum Corporation (NYSE:SOLV) Shares Sold by Arizona State Retirement System
Arizona State Retirement System trimmed its holdings in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 0.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 42,466 shares of the company’s stock after selling 173 shares during the period. Arizona […] - 2025-07-17 05:51:11
Morgan Stanley Upgrades Solventum (NYSE:SOLV) to Overweight
Solventum (NYSE:SOLV – Get Free Report) was upgraded by research analysts at Morgan Stanley from an “equal weight” rating to an “overweight” rating in a research report issued on Tuesday, Marketbeat.com reports. The brokerage presently has a $103.00 target price on the stock, up from their prior target price of $80.00. Morgan Stanley’s price target […] - 2025-07-17 05:00:52
Solventum Corporation (NYSE:SOLV) Shares Sold by Stratos Wealth Partners LTD.
Stratos Wealth Partners LTD. lessened its stake in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 50.6% in the 1st quarter, Holdings Channel reports. The firm owned 4,256 shares of the company’s stock after selling 4,355 shares during the period. Stratos Wealth Partners LTD.’s holdings in Solventum were worth $324,000 at the end of […] - 2025-07-16 04:58:53
Solventum Corporation (NYSE:SOLV) Shares Sold by D.A. Davidson & CO.
D.A. Davidson & CO. lowered its holdings in Solventum Corporation (NYSE:SOLV – Free Report) by 11.8% in the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 7,478 shares of the company’s stock after selling 1,002 shares during the period. D.A. Davidson & CO.’s holdings in Solventum were worth […] - 2025-07-11 05:26:54
Solventum Corporation (NYSE:SOLV) Receives $81.50 Average Price Target from Analysts
Shares of Solventum Corporation (NYSE:SOLV – Get Free Report) have been assigned an average rating of “Hold” from the eleven research firms that are covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and three have assigned a buy rating to […] - 2025-07-07 02:06:56
Solventum Corporation (NYSE:SOLV) Position Lessened by Cambridge Investment Research Advisors Inc.
Cambridge Investment Research Advisors Inc. reduced its holdings in Solventum Corporation (NYSE:SOLV – Free Report) by 4.5% during the 1st quarter, HoldingsChannel reports. The firm owned 18,893 shares of the company’s stock after selling 895 shares during the quarter. Cambridge Investment Research Advisors Inc.’s holdings in Solventum were worth $1,437,000 as of its most recent […] - 2025-07-04 04:32:51
Sumitomo Mitsui Trust Group Inc. Sells 586 Shares of Solventum Corporation (NYSE:SOLV)
Sumitomo Mitsui Trust Group Inc. reduced its holdings in Solventum Corporation (NYSE:SOLV – Free Report) by 0.2% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 319,689 shares of the company’s stock after selling 586 shares during the period. Sumitomo Mitsui Trust Group Inc.’s holdings in Solventum were worth $24,309,000 at the end of […] - 2025-07-03 05:35:09
Robeco Institutional Asset Management B.V. Purchases 2,544 Shares of Solventum Corporation (NYSE:SOLV)
Robeco Institutional Asset Management B.V. lifted its position in Solventum Corporation (NYSE:SOLV – Free Report) by 8.9% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 31,238 shares of the company’s stock after purchasing an additional 2,544 shares during the quarter. Robeco Institutional Asset Management […] - 2025-07-02 06:14:53
Mirae Asset Global Investments Co. Ltd. Decreases Position in Solventum Corporation (NYSE:SOLV)
Mirae Asset Global Investments Co. Ltd. cut its stake in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 5.3% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 56,617 shares of the company’s stock after selling 3,174 shares […] - 2025-07-02 05:35:01
Perigon Wealth Management LLC Acquires 159 Shares of Solventum Corporation (NYSE:SOLV)
Perigon Wealth Management LLC raised its holdings in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 3.8% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 4,352 shares of the company’s stock after acquiring an additional 159 shares during the quarter. Perigon Wealth […] - 2025-07-01 05:09:18
Solventum Corporation (NYSE:SOLV) Shares Purchased by Sequoia Financial Advisors LLC
Sequoia Financial Advisors LLC increased its stake in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 137.0% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,344 shares of the company’s stock after purchasing an additional 10,027 shares during the quarter. […] - 2025-06-30 06:10:48

iShares Core S&P 500 UCITS ETF USD (Dist) SOLV holdings

DateNumber of SOLV Shares HeldBase Market Value of SOLV SharesLocal Market Value of SOLV SharesChange in SOLV Shares HeldChange in SOLV Base ValueCurrent Price per SOLV Share HeldPrevious Price per SOLV Share Held
2025-09-18 (Thursday)52,508SOLV holding increased by 20USD 3,905,020SOLV holding increased by 17234USD 3,905,02020USD 17,234 USD 74.37 USD 74.07
2025-09-17 (Wednesday)52,488SOLV holding increased by 20USD 3,887,786SOLV holding decreased by -1667USD 3,887,78620USD -1,667 USD 74.07 USD 74.13
2025-09-16 (Tuesday)52,468USD 3,889,453SOLV holding increased by 48271USD 3,889,4530USD 48,271 USD 74.13 USD 73.21
2025-09-15 (Monday)52,468USD 3,841,182USD 3,841,182
2025-09-12 (Friday)52,468USD 3,850,627USD 3,850,627
2025-09-11 (Thursday)52,488USD 3,873,090USD 3,873,090
2025-09-10 (Wednesday)52,468USD 3,736,771USD 3,736,771
2025-09-09 (Tuesday)52,468USD 3,824,917USD 3,824,917
2025-09-08 (Monday)52,468USD 3,914,113USD 3,914,113
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of SOLV by Blackrock for IE0031442068

Show aggregate share trades of SOLV

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-09-18BUY20 74.370* 72.31
2025-09-17BUY20 74.070* 72.31
2025-08-19SELL-40 72.270* 72.30 Profit of 2,892 on sale
2025-08-15BUY3,864 71.420* 72.31
2025-08-13SELL-90 74.380* 72.30 Profit of 6,507 on sale
2025-08-12SELL-234 72.090* 72.30 Profit of 16,918 on sale
2025-08-07SELL-270 71.950* 72.30 Profit of 19,521 on sale
2025-08-05BUY18 72.430* 72.30
2025-07-31BUY54 71.360* 72.30
2025-07-28BUY18 73.770* 72.28
2025-07-25SELL-36 74.750* 72.27 Profit of 2,602 on sale
2025-07-18BUY18 73.280* 72.25
2025-07-14SELL-18 74.070* 72.22 Profit of 1,300 on sale
2025-07-08SELL-36 75.080* 72.17 Profit of 2,598 on sale
2025-07-02BUY108 78.250* 72.03
2025-06-24SELL-36 74.980* 71.94 Profit of 2,590 on sale
2025-06-23SELL-18 73.250* 71.93 Profit of 1,295 on sale
2025-06-20SELL-108 73.570* 71.92 Profit of 7,767 on sale
2025-06-12SELL-54 74.290* 71.89 Profit of 3,882 on sale
2025-06-11SELL-1,237 74.410* 71.87 Profit of 88,908 on sale
2025-06-06BUY19 74.840* 71.81
2025-06-02SELL-57 73.120* 71.74 Profit of 4,089 on sale
2025-05-29SELL-19 72.610* 71.73 Profit of 1,363 on sale
2025-05-27BUY19 72.530* 71.71
2025-05-23BUY19 70.810* 71.73
2025-05-21SELL-57 72.760* 71.71 Profit of 4,088 on sale
2025-05-15BUY76 72.940* 71.63
2025-05-14SELL-114 71.140* 71.64 Profit of 8,167 on sale
2025-05-13SELL-228 73.520* 71.62 Profit of 16,330 on sale
2025-05-07SELL-57 65.490* 71.70 Profit of 4,087 on sale
2025-05-02SELL-19 67.620* 71.81 Profit of 1,364 on sale
2025-04-29SELL-57 66.250* 71.95 Profit of 4,101 on sale
2025-04-24BUY19 67.530* 72.08
2025-04-22BUY76 64.940* 72.19
2025-04-16BUY19 65.670* 72.42
2025-04-15BUY19 65.930* 72.48
2025-04-11BUY38 66.190* 72.57
2025-04-09BUY95 68.580* 72.67
2025-04-08BUY285 63.010* 72.76
2025-04-07SELL-133 65.320* 72.83 Profit of 9,686 on sale
2025-04-04SELL-285 66.200* 72.89 Profit of 20,774 on sale
2025-04-02SELL-57 76.620* 72.86 Profit of 4,153 on sale
2025-04-01SELL-19 76.340* 72.82 Profit of 1,384 on sale
2025-03-31SELL-38 76.040* 72.79 Profit of 2,766 on sale
2025-03-28BUY38 74.750* 72.77
2025-03-25BUY57 74.930* 72.71
2025-03-24BUY76 74.200* 72.70
2025-03-21SELL-38 73.970* 72.68 Profit of 2,762 on sale
2025-03-20BUY38 74.990* 72.66
2025-03-19BUY76 76.310* 72.62
2025-03-17SELL-57 75.150* 72.57 Profit of 4,136 on sale
2025-03-14SELL-38 74.160* 72.55 Profit of 2,757 on sale
2025-03-13SELL-114 72.300* 72.56 Profit of 8,271 on sale
2025-03-11SELL-133 75.890* 72.50 Profit of 9,643 on sale
2025-03-10SELL-76 77.640* 72.45 Profit of 5,506 on sale
2025-03-06SELL-76 75.740* 72.35 Profit of 5,498 on sale
2025-03-05SELL-114 77.830* 72.29 Profit of 8,241 on sale
2025-03-04SELL-152 78.990* 72.21 Profit of 10,976 on sale
2025-02-28SELL-95 79.750* 72.03 Profit of 6,843 on sale
2025-02-26BUY38 84.040* 71.74
2025-02-24BUY38 76.280* 71.54
2025-02-21BUY19 73.020* 71.52
2025-02-20SELL-57 74.500* 71.49 Profit of 4,075 on sale
2025-02-14SELL-19 74.240* 71.34 Profit of 1,355 on sale
2025-02-13SELL-247 74.310* 71.30 Profit of 17,611 on sale
2025-02-12SELL-19 73.680* 71.27 Profit of 1,354 on sale
2025-02-06SELL-76 74.780* 71.11 Profit of 5,404 on sale
2025-02-05BUY19 74.790* 71.05
2025-02-04BUY133 74.610* 71.00
2025-01-29SELL-133 74.500* 70.79 Profit of 9,415 on sale
2025-01-28BUY38 74.880* 70.72
2025-01-24BUY19 74.990* 70.58
2025-01-22BUY38 73.660* 70.47
2025-01-16BUY38 72.690* 70.25
2025-01-15BUY19 72.030* 70.22
2025-01-10BUY38 67.070* 70.32
2025-01-02BUY57 65.930* 70.47
2024-12-31BUY38 66.060* 70.56
2024-12-27BUY19 66.740* 70.75
2024-12-20BUY57 66.830* 71.15
2024-12-19BUY19 66.800* 71.27
2024-12-18SELL-19 66.890* 71.38 Profit of 1,356 on sale
2024-12-17BUY38 68.600* 71.46
2024-12-13BUY19 69.560* 71.57
2024-12-10BUY19 69.720* 71.66
2024-12-06SELL-38 69.960* 71.75 Profit of 2,727 on sale
2024-12-05BUY19 69.570* 71.82
2024-12-04SELL-152 70.260* 71.88 Profit of 10,925 on sale
2024-12-03BUY57 70.770* 71.92
2024-12-02BUY95 71.990* 71.91
2024-11-27BUY19 72.480* 71.88
2024-11-26BUY133 71.490* 71.90
2024-11-21BUY57 69.630* 72.08
2024-11-20BUY38 68.390* 72.28
2024-11-19BUY19 67.050* 72.57
2024-11-18BUY38 67.120* 72.89
2024-11-12BUY76 70.700* 73.03
2024-11-11BUY38 71.530* 73.13
2024-11-08BUY152 72.430* 73.18
2024-11-07BUY133 75.070* 73.03
2024-11-06BUY152 74.140* 72.94
2024-11-05SELL-38 73.160* 72.92 Profit of 2,771 on sale
2024-11-04BUY38 72.170* 72.99
2024-11-01BUY133 72.460* 73.05
2024-10-28BUY95 73.360* 72.92
2024-10-25BUY209 73.190* 72.85
2024-10-23SELL-19 72.500* 72.85 Profit of 1,384 on sale
2024-10-21BUY19 73.100* 0.00
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of SOLV

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19179,6991247,01572.7%
2025-09-18190,93029298,08864.1%
2025-09-17498,6723687,70572.5%
2025-09-16228,165327380,92959.9%
2025-09-15554,89912778,87471.2%
2025-09-12588,13632828,29371.0%
2025-09-11246,9841766,54132.2%
2025-09-10188,827332335,56456.3%
2025-09-09188,522332341,42855.2%
2025-09-08365,458198631,15357.9%
2025-09-05127,61129238,25053.6%
2025-09-04156,465248253,84361.6%
2025-09-03159,378103300,28253.1%
2025-09-02159,60986281,26256.7%
2025-08-29113,32429255,67244.3%
2025-08-28190,310320342,93655.5%
2025-08-27156,02590316,14649.4%
2025-08-26123,604121173,81171.1%
2025-08-25156,1157260,24160.0%
2025-08-22240,180367380,07963.2%
2025-08-21140,496278208,89267.3%
2025-08-20154,256530300,20351.4%
2025-08-19141,00824317,43144.4%
2025-08-18272,5350526,91751.7%
2025-08-15397,918956744,78953.4%
2025-08-14785,818571,905,07941.2%
2025-08-13139,646264281,31249.6%
2025-08-1275,373138215,21035.0%
2025-08-11132,362550245,32754.0%
2025-08-08354,273107703,52250.4%
2025-08-07343,61845670,94451.2%
2025-08-06174,8056282,65761.8%
2025-08-05167,8260258,80264.8%
2025-08-04184,021466312,37558.9%
2025-08-01157,693108263,71559.8%
2025-07-31101,7588215,51047.2%
2025-07-3082,277230159,10351.7%
2025-07-2954,40929136,96039.7%
2025-07-2875,6080149,49950.6%
2025-07-2586,7330172,97050.1%
2025-07-2480,110112147,49954.3%
2025-07-2371,97091163,99143.9%
2025-07-2287,106348175,00649.8%
2025-07-2168,91526139,86949.3%
2025-07-1874,959145166,55545.0%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.